Literature DB >> 14745246

[Clinical characteristics at diagnosis and course of Korean patients with Crohn's disease].

Jong Beom Park1, Suk-Kyun Yang, Seung Jae Myung, Jeong-Sik Byeon, Yun Jung Lee, Gin Hyug Lee, Hwoon-Yong Jung, Weon-Seon Hong, Jin Ho Kim, Young Il Min.   

Abstract

BACKGROUND/AIMS: The aim of this study was to evaluate the clinical characteristics and course of Korean patients with Crohn's disease (CD).
METHODS: A total of 113 patients who were newly diagnosed as having CD at the Asan Medical Center between October 1989 and December 2001 were included.
RESULTS: The male to female ratio was 1.9:1 and the mean age at diagnosis was 24.2 +/- 7.8 years. The disease location was the small bowel in 19.5%, the large bowel in 11.5%, and the both small and large bowels in 69.0% of the patients. Empirical anti-tuberculous medications were administered to 53 cases (46.9%). Major complications of CD were intestinal obstruction (25.7%) and perianal fistula (42.5%). The cumulative remission rate was 75.7% at 1 year and 80.7% at 3 years from diagnosis. The cumulative relapse rate was 30.7% at 1 year and 53.0% at 3 years from remission. The cumulative operation rate was 11.5% at 1 year and 13.1% at 3 years from diagnosis.
CONCLUSIONS: There are no differences in the remission and recurrence rates between Korean and Western patients with CD. Although the cumulative operation rate seems to be lower in Korea than in Western countries, the cause of the difference is uncertain. Further studies are needed to determine the characteristics of CD in Korea.

Entities:  

Mesh:

Year:  2004        PMID: 14745246

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  10 in total

1.  Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Authors:  Eun Soo Kim; Won Ho Kim
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

Review 2.  Effectiveness of interferon-gamma release assays for differentiating intestinal tuberculosis from Crohn's disease: a meta-analysis.

Authors:  Wen Chen; Jun-Hua Fan; Wei Luo; Peng Peng; Si-Biao Su
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

3.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

4.  Confluent granulomas and ulcers lined by epithelioid histiocytes: new ideal method for differentiation of ITB and CD? A meta analysis.

Authors:  Juan Du; Yan-Yan Ma; Ha Xiang; You-Ming Li
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

5.  Characteristics of Pediatric Inflammatory Bowel Disease in Korea: Comparison with EUROKIDS Data.

Authors:  Hyeon Ah Lee; Jung Yoon Suk; Sung Youn Choi; Eun Ran Kim; Young-Ho Kim; Chang Kyun Lee; Kyu Chan Huh; Kang Moon Lee; Dong Il Park
Journal:  Gut Liver       Date:  2015-11-23       Impact factor: 4.519

Review 6.  Endoscopic Diagnosis and Differentiation of Inflammatory Bowel Disease.

Authors:  Ji Min Lee; Kang-Moon Lee
Journal:  Clin Endosc       Date:  2016-07-29

7.  The usefulness of angiotensin converting enzyme in the differential diagnosis of Crohn's disease and intestinal tuberculosis.

Authors:  Chang-Il Kwon; Pil Won Park; Haeyoun Kang; Gwang Il Kim; Sung Tae Cha; Kyung Soo Kim; Kwang Hyun Ko; Sung Pyo Hong; Seong Gyu Hwang; Kyu Sung Rim
Journal:  Korean J Intern Med       Date:  2007-03       Impact factor: 2.884

Review 8.  Epidemiology of inflammatory bowel diseases in iran and Asia; a mini review.

Authors:  Ali Reza Safarpour; Seyed Vahid Hosseini; Davood Mehrabani
Journal:  Iran J Med Sci       Date:  2013-06

Review 9.  Crohn's disease in Korea: past, present, and future.

Authors:  Kang-Moon Lee; Ji Min Lee
Journal:  Korean J Intern Med       Date:  2014-08-28       Impact factor: 2.884

10.  Clinical features of Crohn's disease in Korean patients residing in Busan and Gyeongnam.

Authors:  Eun Ji Lee; Tae Oh Kim; Geun Am Song; Jong Hun Lee; Hyung Wook Kim; Sam Ryong Jee; Seun Ja Park; Hyun Jin Kim; Jong Ha Park
Journal:  Intest Res       Date:  2016-01-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.